|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 68.8 TWD | +0.29% |
|
+1.18% | +5.68% |
| 06-28 | Tanvex BioPharma, Inc. Announces CFO Changes, Effective June 30, 2024 | CI |
| 06-19 | Tanvex BioPharma, Inc. Appoints Val Chen as Corporate Governance Officer, Effective July 1, 2024 | CI |
Tanvex BioPharma, Inc. announced resignation of James Williamson as Corporate Controller. Reason for the change is personal related factor.
| 1st Jan change | Capi. | |
|---|---|---|
| +5.68% | 346M | |
| +19.61% | 126B | |
| +24.93% | 118B | |
| +24.69% | 27.87B | |
| -16.74% | 20.95B | |
| -14.80% | 16.92B | |
| -13.51% | 16.18B | |
| +11.00% | 14.84B | |
| -47.10% | 14.79B | |
| +53.48% | 14.08B |
TANVEX BIOPHARMA, INC. 
